Amnovis, BAAT Medical Collaborate on 3D Printed Medical Devices

Amnovis and BAAT Medical are collaborating to provide innovative and faster turnaround processes for 3D printed medical devices, spanning the complete process — from initial idea to a certified product ready for use. 

By sharing their business focus and technology expertise, Amnovis and BAAT Medical are striving to create more innovative business models and better 3D printed medical devices. Their joint technology roadmap will be focused on the development of new medical device applications and the validation of state-of-the-art additive manufacturing (AM) technologies and related processes to push medical device innovation. 

The collaboration is also designed to enable medical device startups and OEMs to benefit from faster time to market of 3D printed medical devices which excel in patient outcome.

BAAT Medical is experienced in the engineering and development of 3D printed spinal fusion implants, resulting in multiple CE marks and FDA approvals, and more than 50,000 implants manufactured to date. The Amnovis founders have a proven track record, going back to 2008, in using AM to make high-end products. It was among the first to employ L-PFB for printing titanium medical devices such as orthopedic and spinal implants.

The collaboration between Amnovis and BAAT Medical is said to combine the best of both companies. Together, they say they have a more comprehensive view on how to optimally tune design and development as well as material selection and manufacturing in the context of specific AM medical device applications. 

“As preferred partners, our joint offering comprises of the complete process for customers and prospects to aim high and move fast, while removing hurdles in medical device development, validation and manufacturing,” says Ruben Wauthle, Amnovis CEO and co-founder.

Working together, the companies want to push the innovative edge of medical device OEMs and move faster through the development, validation and manufacturing stages.

“We believe that efficiency in development and production throughout the whole chain is essential to keep investments in innovations of medical devices feasible, especially for European markets where the MDR is a reality,” says Gert Nijenbanning, BAAT Medical managing director. “Together, we want to build on the complementary expertise of Amnovis and BAAT Medical to collaborate and take 3D printing of medical devices to the next level.”